Objectives: Laser interstitial thermal therapy (LITT) is a minimally invasive surgical technique for focal epilepsy. A major appeal of LITT is that it may result in fewer cognitive deficits, especially when targeting dominant hemisphere mesial temporal lobe (MTL) epilepsy. To evaluate this, as well as to determine seizure outcomes following LITT, we evaluated the relationships between ablation volumes and surgical or cognitive outcomes in 43 consecutive patients undergoing LITT for MTL epilepsy. Methods: All patients underwent unilateral LITT targeting mesial temporal structures. FreeSurfer software was used to derive cortical and subcortical segmentation of the brain (especially subregions of the MTL) using preoperative magnetic resonance imaging (MRI). Ablation volumes were outlined using a postablation T1-contrasted MRI. The percentages of the amygdala, hippocampus, and entorhinal cortex ablated were quantified objectively. The volumetric measures were regressed against changes in neuropsychological performance before and after surgery, Results: A median of 73.7% of amygdala, 70.9% of hippocampus, and 28.3% of entorhinal cortex was ablated. Engel class I surgical outcome was obtained in 79.5% and 67.4% of the 43 patients at 6 and 20.3 months of follow-up, respectively. No significant differences in surgical outcomes were found across patient subgroups (hemispheric dominance, hippocampal sclerosis, or need for intracranial evaluation). Furthermore, no significant differences in volumes ablated were found between patients with Engel class IA vs Engel class II-IV outcomes. In patients undergoing LITT in the dominant hemisphere, a decline in verbal and narrative memory, but not in naming function was noted. Significance: Seizure-free outcomes following LITT may be comparable in carefully selected patients with and without MTS, and these outcomes are comparable with outcomes following microsurgical resection. Failures may result from nonmesial components of the epileptogenic network that are not affected by LITT.
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Cognitive declines following MTL-LITT are modest, and principally affect memory processes.
| INTRODUCTION
MRI-guided laser interstitial thermal ablation (MRIgLITT) was initially used as surgical treatment for patients with liver metastases, 1 tumors, and gliomas. 2 Over the past 5 years, Visualase (Medtronic, Englewood, CO, USA) and NeuroBlate systems (formerly AutoLITT, Monteris Medical, Inc, Plymouth, MN, USA), 3 gained acceptance for the treatment of epilepsy, and MRIgLITT became a widely used surgical alternative for mesial temporal lobe (MTL) epilepsy, [3] [4] [5] [6] [7] [8] [9] [10] hypothalamic hamartomas, 11 periventricular nodular heterotopia, 12, 13 cavernous malformations, 14 and focal cortical dysplasias. 15 The application of MRIgLITT in these cases is particularly appealing as it allows for a targeted lesioning of the putative ictal-onset zone, with little or no collateral damage. This aspect of LITT coupled with its minimally invasive nature have made this procedure gain rapid adoption: almost 200 cases have been reported thus far where MRIgLITT was used instead of classical anteromesial temporal resections in patients with MTL epilepsy (MTLE) as of 2017. However, the published reports chiefly attest to the safety and the efficacy of the technique for the treatment of MTLE, 16 a handful of studies that have examined cognitive outcomes following LITT. 6, 7, 9, [17] [18] [19] [20] Moreover, the impact of preoperative epilepsy-related deficits in language and memory, and of mesial temporal atrophy, on seizure and cognitive outcome, have not yet been well characterized. We report here, a series of 43 consecutive laser ablations of the amygdala and hippocampus for the treatment of MTLE over an interval of 5 years (6/2012-6/2017), making this one of the larger series reported thus far. The relatively large numbers allow us to model the interplay between mesial temporal atrophy, presurgical cognitive states, and volumes of ablation on the outcomes. Specifically, we hypothesize that with careful patient selection and, if needed, intracranial recordings, surgical outcomes in nonlesional MTLE localized to the mesial structures should be similar to those in patients with mesial temporal sclerosis (MTS). In addition, we anticipate that outcomes in series of carefully selected patients undergoing optimal ablation should not be dissimilar compared with those seen after traditional resective surgeries, as both techniques chiefly target the same brain regions, even though the extent of ablated/resected tissue is significantly different with the 2 surgical techniques. Contrary to a common preconception, Kang et al, 6 showed that larger ablation volumes are not correlated with better surgical outcomes. Furthermore, we aim to elaborate the relationship between the volumes of ablation in specific mesial temporal subregions with the language and memory deficits following MRIgLITT using high-resolution magnetic resonance imaging (MRI) and detailed neuropsychological testing pre-and postsurgery. Indeed, the evaluation of LITT for carefully selected MTLE cases with MTS, in prospective fashion, is the goal of the ongoing Stereotactic Laser Ablation for Temporal Lobe Epilepsy (SLATE) trial (ClinicalTrials.gov identifier NCT02844465). None of the patients described herein are part of that trial.
| METHODS

| Patient details
Forty-three adult patients diagnosed with either left or right MTLE underwent LITT of the amygdala and hippocampus. A total of 58 consecutive LITT surgeries were performed at Memorial Hermann-Texas Medical Center Hospital by the senior author between June 2012 and June 2017. Some of these cases were performed for brain tumors (n = 7), periventricular heterotopias (n = 6), cavernomas (n = 1), and hypothalamic hamartomas (n = 1). All data were compiled after approval of the study by the local Committee for the Protection of Human Subjects and in accordance with established standards for human subjects research.
Key Points
• In 43 patients undergoing LITT for MTLE, Engel class I outcomes were obtained in 80% at 6, and 67% at 20.3 months, respectively
• Surgical outcomes were uncorrelated with the percentage of ablation of the mesial temporal structures
• LITT in the dominant hemisphere led to small but significant declines in memory, but no declines in naming
• 55 .8% of patients were male, and the patients failed an average of 3.8 AE 1.8 anticonvulsants before being referred to surgical treatment. Individual demographic details, seizure semiology, scalp electrophysiology, neuropsychological testing, and preoperative MRI well as nuclear medicine imaging findings (if performed) were compiled. All cases were reviewed at a multidisciplinary conference comprising a neurosurgeon, epileptologists, a neuroradiologist, and a neuropsychologist. The degree of hippocampal sclerosis on MRI was characterized. The rationale for the proposed procedure as well as that for an intracranial evaluation (if performed) was documented in the surgical management conference notes. Data relating to this decision making-including seizure semiology, scalp electroencephalography (EEG) findings, imaging, intracranial electrophysiology and, as well as cognitive assessment by the neuropsychologist, were all compiled. All patients underwent preoperative assessment with a specific and standardized epilepsy protocol MRI scan in a Philips 3T scanner (Philips, Andover, MA, USA). Only patients with an existing vagus nerve stimulation (VNS) implant were scanned on a 1.5T scanner (n = 4). In all cases, the T1 volumetric images (magnetization-prepared rapid gradient-echo [MPRAGE]) had adequate signal-to-noise ratio (SNR) to allow for automated segmentation. Thirtyfour patients had imaging evidence of MTS, visually identified by an expert radiologist (EF), of which 17 patients additionally underwent stereo-EEG investigations. Nine patients did not have imaging evidence of MTS, of which 2 had LITT without additional SEEG investigations. One of these 2 patients had a dysembryoplastic neuroepithelial tumor (DNET) in the left amygdala and head of the hippocampus, whereas the second patient had undergone prior left temporal lobectomy and frontal opercular resection, and LITT was used to ablate a residual hippocampal tissue.
The intracarotid amytal (Wada) test 21 was performed in 16 patients: 14 had left hemisphere dominance and 2 had right language hemisphere dominance. Ten patients underwent language functional MRI (fMRI)-8 patients were left lateralized and 2 were right lateralized. Six patients underwent cortical stimulation mapping (CSM), of which 5 patients had language-positive sites on the left hemisphere, and 1 patient had language-positive sites on the right hemisphere. Thus, hemispheric dominance was determined by the Wada in 37%, fMRI in 14%, and by CSM in 2% cases. For patients not tested with intracarotid amytal (n = 20, 47%), we assumed that the left hemisphere was dominant hemisphere, as they were right handed and their pre-and postoperative neuropsychological profile was concordant with deficits in the dominant hemisphere-declines in verbal memory and/or fluency. 22 
| Surgical procedure
A Medtronic Visualase MRI-guided Laser Ablation system was used to perform LITT. The basic principles of LITT, as well as the Visualase system have been described previously. 3 The specifics of the surgical procedure have been detailed in prior publications. 12 All patients underwent a volumetric T1-weighted, T2-weighted scan and fluid-attenuated inversion recovery (FLAIR) scans prior to surgery. On the day of the procedure they underwent a computed tomography (CT) angiogram with an N Box connected to the Leksell (Elekta, Stockholm, Sweden) frame attached to the skull. A stereotactic planning workstation (Framelink or Cranial Stealth navigation system, Medtronic) was used to design trajectories optimized to allow maximal traversal of the medial temporal structures while avoiding blood vessels and the ventricle. In all cases, an occipital entry point was used to target the long axis of the hippocampus, and the trajectory was optimized to ablate as much of the amygdala as possible ( Figure 1 ). In many cases, the trajectory spared the hippocampus tail. A stab incision was made in the scalp via which a 3.2 mm drill hole was made using a Salcman drill guide precisely positioned using the Leksell frame. After the dura was coagulated, a 1.65 mm diameter saline-cooled polycarbonate 23 laser applicator sheath (Visualase, Inc., Houston, TX, USA) was placed to the target using a guide rod via either a polycarbonate or titanium anchor bolt placed in the skull. The precise length of the probe, as well as confirmation of the positioning, was determined using intraoperative fluoroscopic navigational guidance. After placement of the laser applicator sheath, the Leksell frame was removed and a laser fiber (400 lm core silica fiber-optic cable with a 10 mm cylindrical diffusing tip) was placed into the sheath. The patient was transported under general anesthesia to a 3.0T MRI scanner (General Electric Signa EXCITE, Milwaukee, WI, USA) where a standard quadrature head coil was placed. Precise placement of the laser probe was confirmed using a volumetric T1 acquisition reformatted in all 3 cardinal planes.
The ablation was monitored in 2 oblique views, each orthogonal to the other, chosen such that the full length of the probe was visible. MR thermal imaging was acquired continuously throughout the therapy, with a time resolution of 5 seconds, using scanner parameters and procedures described previously. 12 Thermal images were processed on the Visualase work station and color-coded temperature maps and thermal damage estimates were overlaid on the structural MR images in near real time. Temperature DONOS ET AL.
| 1423 control points were placed in the ventral thalamus to deactivate the laser if at any time during the treatment the estimated temperature exceeded 50°C. Additional control points were placed along the long axis of the fiber to deactivate the laser if the computed temperature exceeded a temperature of 90°C, to prevent steam formation or melting 
of the polycarbonate sheath. Low-power test pulses were initially applied (3-4 W, 15-45 seconds) to verify locus of thermal delivery prior to ablation. Ablation was carried out at between 60 and 95% of the peak output of the 15W laser. Once ablation at a given site was judged as satisfactory (generally 1-3 minutes), based on real time monitoring of the damage map by the neurosurgeon in the MRI control room, the laser fiber was manually withdrawn in small increments to produce a cylindroidal thermal lesion along the trajectory. After ablation was complete, a postablation T1 contrast MRI was used to directly evaluate the extent of ablation, and to derive confirmation of the targeting. Thereafter, the laser applicator was fully withdrawn, the anchor bolt removed, and the incision was closed. Surgical outcomes in all cases were assessed based on Engel classification and a Kaplan-Meier estimator 24 was used to approximate the survival curve for Engel IA and Engel I surgical outcomes. The survival curves (seizure freedom) were computed using data points at 6, 12, and 24-month follow-up. Patients that did not experience a change in surgical outcome or were not followed throughout the 24-month period were censored.
| Ablation volume measurements
In each case, the presurgical high-resolution T1 MRI without contrast was analyzed using FreeSurfer software for brain segmentation 25 and parcellation of cortical 26 and subcortical 27 structures, as well as 13hippocampal
subfields. 28 The parcellation results were visually inspected in all cases. Of the 43 LITT procedures, parcellation could be readily validated in 39 patients. Segmentation errors occurred in 4 patients who had either a high degree of cerebral loss (n = 3) or previous brain surgery (n = 1). These cases were discarded from the volumetric based analyses without attempting to manually correct the parcellation. 29 The postablation T1 contrast MRI was registered to FreeSurfer's output using "bbregister," a FreeSurfer command that performs a rigid, within-subject, cross-modal registration using a boundarybased cost function. 30 The ablation volume was manually marked on the coronal slices. This volume-of-interest was exported as a separate ablation volume mask. The percentage of amygdala, parahippocampus, entorhinal cortex, and hippocampal subfields that were part of the ablation volume mask were computed as:
where N total is the total number of 1 mm 3 voxels assigned to a brain structure and N ablated is the number of 1 mm 3 voxels assigned to a brain structure in the pre-op parcellation, that overlaps with the ablation volume mask (Figure 2) . N-way ANOVAs were used to assess the relation between preablation hippocampal and amygdala volumes, 
The Hemisphere dominance column includes the decisive factor in parenthesis. Wherever the decisive factor is unspecified, the hemisphere dominance was assumed left. AMB, ambidextrous; CSM, cortical stimulation mapping. | 1425 the hemisphere dominance, and the use of SEEG to localize the seizure onset. These ANOVAs were performed for both the ablation and the healthy hemisphere.
F I G U R E 1
| Neuropsychological testing
Although all patients had neuropsychological assessment prior to surgery, some of them did not return for postsurgery neuropsychological testing (n = 8); therefore 31 of the 39 patients for whom we measured ablation volume were included in the correlational analysis of cognitive deficits and ablation volumes. Analyses were grouped based on whether ablation was in the dominant or nondominant hemisphere. To assess the significant changes in neuropsychological scores at a group level, a Wilcoxon rank-sum test between pre-and postablation scores for each neuropsychological test was performed (P < .05).
For all relevant neuropsychological tests, we computed the postablation cognitive change (PACC) as the difference between the post-and preablation scores. We performed linear regressions for each neuropsychological test, using PACC as dependent variable and a set of 4 predictors: preablation neuropsychological score, pre-ablation hippocampal volume, percent of ablation of the hippocampus, and percent of ablation of entorhinal cortex. The entorhinal cortex was included as predictor due to its known involvement in memory and spatial processing. 37 As individuals with higher performance scores in presurgical neuropsychological tests are known to exhibit larger decrements in cognitive function postsurgery, 38 the preablation neuropsychological score was included as a predictor in the regression model. 39 Ideally, all brain structures included in the ablation volume would be part of the regression model; however, given the large number of structures relative to the number of patients and the high degree of collinearity between percentages of ablation for each structure, we restricted the analysis to the hippocampus and entorhinal cortices, and could not reasonably model the interactions with subregions.
| RESULTS
Forty-three patients underwent LITT for MTLE over a 5-year interval. Of these, 34 patients had imaging evidence of MTS. The mean f/u duration was 20.3 months (AE13.8 SD). Thirty-six patients were followed for greater than 6 months, and 18 patients for greater than 1 year. Thirtyone patients had f/u neuropsychological evaluations doneall at approximately 6 months after LITT (mean 6.14 months, SD 1.2 months).
| Surgical and seizure outcomes
No patients had any hemorrhage, infection, cranial nerve deficits, or new neurological deficits immediately following the procedure. One patient developed an optic neuritis about 6 weeks postprocedure (reported in Morris et al 40 Figure 3A ). The distribution of surgical outcomes was computed for patient groups formed by MTS diagnosis and pre-ablation SEEG investigations and shown in Figure 3B. It appears that non-MTS patients who had SEEG investigations (n = 7) exhibit a lower percentage of Engel class I surgical outcomes (71.4%) compared to patient groups diagnosed with MTS and did not require SEEG investigations prior to MRIgLITT (n = 17), which reached Engel class I in 76.4% of surgeries. However, chi-square tests did not show any statistically significant differences between the percentages obtained by the patient subgroups at P = .05 significance threshold. The preablation volume modeled as a function of MTS, hemisphere dominance, and the usage of intracranial recordings (N-way ANOVA) revealed, as expected, that MTS patients had significantly smaller preablation hippocampal volumes on the side of ablation (F 1,35 = 7.27, P = .011), regardless of hemisphere (F 1,35 = 0.01, P = .928) or the use of intracranial recordings (F 1,35 = 3.38, P = .074). However, in the healthy hemisphere, preablation hippocampal volumes did not show a significant difference regardless of the presence or absence of MTS (F 1,35 = 3.62 P = .065), intracranial investigation (F 1,35 = 0.22, P = .634) or hemisphere dominance (F 1,35 = 0.06, P = .808), confirming that this patient group had lateralized mesial temporal volume loss. Preablation amygdala volumes showed no significant difference between sides.
The Kaplan-Meier estimator showed seizure-free (Engel IA) survival rates of 97% (confidence interval [CI] 92%-100%) at 6 months, 78% (CI 63%-92%) at 12 months, and 60% (CI 39%-81%) at 24 months, and 97% (CI 92%-100%) at 6 months, 85% (CI 73%-97%) at 12 months, and 76% (CI 61%-92%) at 24 months for Engel I outcome (Figure 4 ).
| Ablation volumes
Although the main target of LITT was the amygdala and the hippocampus, nearby structures were partially included in the ablation volume, including parahippocampal and entorhinal cortices, which play an active role in cognition, especially visuospatial processing and episodic memory. 37, 41 In the 39 patient subset for which we quantified the ablation volume, the median AE median absolute deviations of percentage of ablation were 73.7 AE 13.4% of amygdala, 70.9 AE 12.6% of hippocampus, 30.8 AE 9.9% of parahippocampal gyrus, and 28.3 AE 15.3% of entorhinal cortex. Median ablation percentages for CA1, CA2/3, and CA4 hippocampal subfields were 81.7, 88.6, and 90.3%, respectively. Only 3.2% of the hippocampal tail was included in the ablation volume. Of these 39 patients, 20 had Engel IA and 10 had Engel II-IV surgical outcomes at last followup. A Wilcoxon rank-sum test showed no significant difference (P > .05) in percentages of ablated volumes for Engel IA vs II-IV subgroups ( Figure 5 ).
Engel scores were converted to numerical values by ranking them 1 to 5, and an N-way ANOVA was performed to ascertain whether the mean percentage of ablated volumes of amygdala, hippocampus, parahippocampal, and entorhinal cortex were significantly different from each other in respect to the surgical outcome. No significant differences were found (P > .05). In addition, 2-sample t-tests contrasting ablation volumes of each brain structure, for Engel IA and II-IV groups, revealed no statistically significant differences (P > .05). To evaluate this further, we also performed Spearman correlations between ranked Engel scores and percentage of ablation of each structure. Again, percentage of ablation of any brain structure exhibited no significant correlation with surgical outcome (all P-values >0.05).
| Cognitive outcomes
For patients undergoing MRIgLITT in the dominant hemisphere there were no changes in Boston Naming Test or Category and Semantic Fluency tests (Wilcoxon rank-sum test, P > .05). There was a significant decline in Verbal IQ as estimated using the WASI (P = .011), including the Vocabulary (P = .017) and Similarities subtests (P = .022), and a significant improvement in Performance IQ (P = .016), including the Block Design (P = .044) subtest. For the memory tests, there was a decline in the in shortdelay cued recall from the CVLT-II (P = .049) and the immediate recall for the Logical Memory test from the WMS-III (P = .018). For patients with MRIgLITT in the nondominant hemisphere, the only significant finding was for the delayed recall condition of the NVSR (P = .045). The median and median absolute deviation of pre and postsurgical neuropsychological scores are presented in the Data S1. Although the test scores are normally distributed given a large sample (hence the possibility of using standardized T-scores with a mean of 50 and a standard deviation of 10), this does not imply that a small subset of scores (ie, from 11 patients with surgery in the nondominant hemisphere) is also normally distributed. Therefore, medians represent a better approximation of the smaller sample sizes and are used to report the neuropsychological scores. 20 To evaluate effects on language and memory, we grouped patients by surgery in the dominant hemisphere and by MTS diagnosis, that is, they were organized into 4 groups: patients with MTS and ablation in the dominant (MTS-DOM, n = 18) or nondominant hemisphere (MTS-NONDOM, n = 9), and patients without MTS and ablation in the dominant (NONMTS-DOM, n = 2) or nondominant hemisphere (NONMTS-NONDOM, n = 2). We used the Wilcoxon signed-rank test to assess changes in cognitive performance for each neuropsychological test. Significant score decreases in MTS-DOM patients were found for WASI's Verbal IQ (P = .03) and Vocabulary (P = .05) subtests, CVLT-II's Short (P = .005) and Long (P = .038) Delayed Cued Recall, and WMS-III's Logical Memory I Recall subtest (P = .012). A significant score increase for the MTS-DOM group was found in WASI's Performance IQ (P = .004) and Block Design (P = .041). MTS-NON-DOM patients exhibited significant decrease in Logical Memory I Recall performance (P = .016).
Next, for each neuropsychological test, the postablation cognitive change (PACC)-the difference between postand preablation scores-was modelled as a dependent variable against preablation score, preablation hippocampal volume, % hippocampus ablated, and % entorhinal cortex ablated. Five linear regression models were significant in the dominant hemisphere (n = 20), a qualitative description of the results follows; the actual linear regression results are in Table 2 . The significant b values (strength of association) for the preablation neuropsychological scores (NVSR Delayed Recall, CVLT-II Recognition False Alarms, and Table 2 are uncorrected for family-wise error. Given the large number of neuropsychological subtests (n = 39, complete list in the Data S1), the FDR correction is very stringent and no models remain significant after such a correction. Given that this is a relatively new surgical technique, whose potential for neuropsychological impacts is not yet well quantified, we therefore adopted a more conservative approach to impacts on neuropsychological tests by not applying multiple comparison correction methods. This potentially leads to our results including a few false positives, instead of applying a correction that may result in false negatives, and our statements should be viewed in this context. However, in our linear models, the only significant predictor was the presurgical neuropsychological score, which was modeled independently for each test.
Only 11 patients completed the neuropsychological assessment after laser ablation in the nondominant hemisphere; therefore we were unable to create a linear regression model with 4 predictors for these patients.
| DISCUSSION
| Seizure outcomes
We report surgical outcomes for one of the largest MRIgLITT case series (n = 43) thus far of MTLE patients, with or without evidence of mesial temporal sclerosis. We obtained Engel I surgical outcome in 79.5% of patients at 6 months follow-up and 67.4% at last follow-up (~20.3 months). These outcomes are roughly comparable to traditional amygdalo-hippocampectomies 42 and anterior temporal lobe resections, 43 and are better than previously published MRIgLITT case series. 6, [8] [9] [10] Compared to traditional anterior temporal resections, where Engel I surgical outcomes at 2 years of follow-up is obtained for about 67% of patients, 43 the Engel I surgical outcome obtained after MRIgLITT has been viewed as inferior by about 10%-20%. 3, 5, 44, 45 Further, analyzing patients with a diagnosis of MTS and the necessity of SEEG investigations for seizure-onset zone identification revealed no statistically significant differences between the percentages of patients with Engel class I surgical outcomes ( Figure 3B ). This provides a first answer to Kang and Sperling's question 16 whether patients without evidence of mesial temporal sclerosis on MRI scans are good candidates for MRIgLITT. We show that for carefully selected MRI-negative patients, in whom intracranial investigations are generally needed to precisely localize the seizure-onset zone to the hippocampus, MRIgLITT provides a good alternative to traditional open resections. Notably, a median of 73.7% of amygdala and 70.9% of hippocampus were ablated in our patient cohort. This extent of the ablation is larger than in previous publications (% 50%-60% in Kang et al 6 ), which may be one of the reasons for the better seizure outcomes in our series.
In agreement with a previous study, 6 we found no significant differences in the percentages of ablated volumes of hippocampus, amygdala, parahippocampus, and entorhinal cortex for Engel IA vs Engel II-IV surgical outcomes. Although Jermakowicz et al reported that sparing the hippocampal head was associated with poor surgical outcomes, we did not find this relationship in our data. In fact, the median percentage of the hippocampal tail ablated in our patient cohort was 3.2%. This discrepancy may be attributable to methodological differences: we assessed percentages of ablated structures in individual patient space, a precise and patient specific measure of change, whereas Jermakowicz et al performed nonrigid registrations of patients to a standard space, after manually outlining the amygdala and hippocampus on an MPRAGE sequence and computed percentages in that standardized space.
| Cognitive outcomes
A major advantage of the laser ablation approach in the treatment of MTLE, is the reduction of cognitive deficits, especially in the language-dominant hemisphere. 7 The surgical outcomes following MRIgLITT, as discussed in recent review articles, have been viewed as inferior to those of traditional anterior mesial resections, but this is considered a trade-off for better postsurgery cognitive performance. 3, 5, 44 We observed a decline in some aspects of memory: CVLT-II short delayed cued recall, immediate memory from the Logical Memory subtest of WMS-III) and expressive language (Verbal IQ subtest of WASI). However, these changes observed at the group level are small and may not reach the standards of significance defined by reliable change indices and the 1 SD change that has often been reported in the literature. Moreover, the second neuropsychological assessment was performed at 6 months postsurgery; therefore further improvement of cognitive performance is still likely to occur due to functional recovery over the following months. Several verbal and memory deficits (CVLT-II Total 1-5, 6 WMS-III Logical Memory Recall II, 10 and WMS-III Visual Reproduction 18 ), or performance IQ deficit 9 that have been previously reported after MRIgLITT were not significantly changed in our study. In addition, there was no impact detected on naming (Boston Naming Test). Changes in Short Delayed Free Recall scores (CVLT-II) correlated with percentage of entorhinal ablation. Two other tests (CVLT-II's Recognition False Alarms and WMS-III's Logical Memory II Retention), albeit probing dominant hemisphere's language and memory functions, were also correlated with only the preablation neuropsychological score. This is in agreement with previous studies that showed that highly functional individuals are more likely to have a cognitive decline after surgery, despite higher potential of recovery. 46 The NVSR Delayed Recall test probes nonverbal memory, a function that resides in the nondominant hemisphere, 47 and, as might be expected, in our dominant hemisphere regression analyses, changes in this score did not correlate with presurgical hippocampal volumes or percentage of ablation, but correlated with presurgical scores. Most patients in this series did not have any broad-based neurologic disease, they would not be candidates for this highly focused intervention in case they did. Indeed, these are all patients with highly focal epilepsy T A B L E 2 Neuropsychological tests with significant linear regression models (P < .05) for patients who had MRIgLITT in the dominant hemisphere (n = 20) localized to the amygdalo-hippocampal complex according to either intracranial investigations or high-resolution imaging. In this population, this intervention seems to carry the greatest risk in case memory and other cognitive functions are preserved in the MTL being ablated. Our analyses were limited by multicollinearity in the ablation volumes of hippocampal subregions related to the quasi-isotropic spread of heat along the laser trajectory ( Figure 5 ). In addition, although larger than prior series, the size of our cohort precludes us from using each structure that was part of the ablation volume as a predictor in linear regression models. Despite these limitations, it does appear that once the percentage of ablation reaches a certain threshold, the brain networks 48, 49 involved in performing certain functions deteriorate dichotomously. Such "all-or none" effects are not readily modeled by linear regressions. This may explain the distinction between neuropsychological tests that showed a significant change at the group level and those tests for which the regression models based on ablation volumes were significant.
| CONCLUSION
MRIgLITT is an effective treatment for MTLE, with or without imaging evidence of mesial temporal sclerosis. We showed that in MRI-negative cases, SEEG investigations can be used instead to isolate onsets to the mesial structures, and the surgical outcomes in these patients are comparable to those with clear mesial temporal sclerosis diagnosis. The surgical outcomes we obtained are comparable to those obtained with traditional anterior mesial resections, while the cognitive impairments, especially in naming are diminished.
